These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 32251360)
1. Effects of daily L-dopa administration on learning and brain structure in older adults undergoing cognitive training: a randomised clinical trial. Lebedev AV; Nilsson J; Lindström J; Fredborg W; Akenine U; Hillilä C; Andersen P; Spulber G; de Lange ECM; van den Berg DJ; Kivipelto M; Lövdén M Sci Rep; 2020 Mar; 10(1):5227. PubMed ID: 32251360 [TBL] [Abstract][Full Text] [Related]
2. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B; Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749 [TBL] [Abstract][Full Text] [Related]
3. Genetic variation in the human brain dopamine system influences motor learning and its modulation by L-Dopa. Pearson-Fuhrhop KM; Minton B; Acevedo D; Shahbaba B; Cramer SC PLoS One; 2013; 8(4):e61197. PubMed ID: 23613810 [TBL] [Abstract][Full Text] [Related]
4. Modafinil combined with cognitive training is associated with improved learning in healthy volunteers--a randomised controlled trial. Gilleen J; Michalopoulou PG; Reichenberg A; Drake R; Wykes T; Lewis SW; Kapur S Eur Neuropsychopharmacol; 2014 Apr; 24(4):529-39. PubMed ID: 24485800 [TBL] [Abstract][Full Text] [Related]
5. Dopaminergic modulation of hemodynamic signal variability and the functional connectome during cognitive performance. Alavash M; Lim SJ; Thiel C; Sehm B; Deserno L; Obleser J Neuroimage; 2018 May; 172():341-356. PubMed ID: 29410219 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial. Ford GA; Bhakta BB; Cozens A; Hartley S; Holloway I; Meads D; Pearn J; Ruddock S; Sackley CM; Saloniki EC; Santorelli G; Walker MF; Farrin AJ Lancet Neurol; 2019 Jun; 18(6):530-538. PubMed ID: 31122493 [TBL] [Abstract][Full Text] [Related]
7. Levodopa impairs probabilistic reversal learning in healthy young adults. Vo A; Seergobin KN; Morrow SA; MacDonald PA Psychopharmacology (Berl); 2016 Jul; 233(14):2753-63. PubMed ID: 27241710 [TBL] [Abstract][Full Text] [Related]
8. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Cools R; Stefanova E; Barker RA; Robbins TW; Owen AM Brain; 2002 Mar; 125(Pt 3):584-94. PubMed ID: 11872615 [TBL] [Abstract][Full Text] [Related]
9. Effects of long-term testosterone administration on cognition in older men with low or low-to-normal testosterone concentrations: a prespecified secondary analysis of data from the randomised, double-blind, placebo-controlled TEAAM trial. Huang G; Wharton W; Bhasin S; Harman SM; Pencina KM; Tsitouras P; Li Z; Hally KA; Asthana S; Storer TW; Basaria S Lancet Diabetes Endocrinol; 2016 Aug; 4(8):657-665. PubMed ID: 27377542 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial. LeWitt PA; Hauser RA; Pahwa R; Isaacson SH; Fernandez HH; Lew M; Saint-Hilaire M; Pourcher E; Lopez-Manzanares L; Waters C; Rudzínska M; Sedkov A; Batycky R; Oh C; Lancet Neurol; 2019 Feb; 18(2):145-154. PubMed ID: 30663606 [TBL] [Abstract][Full Text] [Related]
11. L-DOPA reduces model-free control of behavior by attenuating the transfer of value to action. Kroemer NB; Lee Y; Pooseh S; Eppinger B; Goschke T; Smolka MN Neuroimage; 2019 Feb; 186():113-125. PubMed ID: 30381245 [TBL] [Abstract][Full Text] [Related]
12. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar. Huang L; Deng M; Zhang S; Fang Y; Li L Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244 [TBL] [Abstract][Full Text] [Related]
13. Folic acid with or without vitamin B12 for cognition and dementia. Malouf M; Grimley EJ; Areosa SA Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018 [TBL] [Abstract][Full Text] [Related]
14. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment. Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809 [TBL] [Abstract][Full Text] [Related]
15. Ginkgo for memory enhancement: a randomized controlled trial. Solomon PR; Adams F; Silver A; Zimmer J; DeVeaux R JAMA; 2002 Aug; 288(7):835-40. PubMed ID: 12186600 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of Cognition Support Formula® on cognitive function in older adults with subjective cognitive impairment: a protocol for a 26-week, randomised, double-blind, placebo-controlled trial. Cave AE; Chang DH; Münch GW; Steiner GZ Trials; 2019 Jun; 20(1):345. PubMed ID: 31182153 [TBL] [Abstract][Full Text] [Related]
17. The effect of vitamin B6 on cognition. Malouf R; Grimley Evans J Cochrane Database Syst Rev; 2003; (4):CD004393. PubMed ID: 14584010 [TBL] [Abstract][Full Text] [Related]